FDA

The U.S. Food and Drug Administration (FDA), an agency within the U.S. Department of Health and Human Services, promotes and protects the public health by, among other things, assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation’s food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

www.fda.gov

FDA RSS Channel

Display # 
Title Published Date
FDA updates warnings for fluoroquinolone antibiotics 26 July 2016
FDA approves new medication for dry eye disease 12 July 2016
FDA advances Precision Medicine Initiative by issuing draft guidances on next generation sequencing-based tests 08 July 2016
FDA targets unlawful internet sales of illegal prescription medicines during International Operation Pangea IX 10 June 2016
FDA approves first buprenorphine implant for treatment of opioid dependence 26 May 2016
FDA approves new treatment for inhalation anthrax 22 March 2016
FDA takes additional action to better understand safety of Essure, inform patients of potential risks 01 March 2016
FDA providing $2 million in new grants for natural history studies in rare diseases 29 February 2016
FDA seeks $5.1 billion total for FY 2017 10 February 2016
Califf, FDA top officials call for sweeping review of agency opioids policies 04 February 2016
FDA approves first drug to show survival benefit in liposarcoma 28 January 2016
FDA approves first drug to treat a rare enzyme disorder in pediatric and adult patients 08 December 2015
FDA approves Opdivo to treat advanced form of kidney cancer 24 November 2015
FDA approves new treatment for HIV 06 November 2015
FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa 19 October 2015
FDA approves new injectable drug to treat schizophrenia 09 October 2015
FDA approves Keytruda for advanced non-small cell lung cancer 05 October 2015
FDA approves first treatment for sexual desire disorder 19 August 2015
FDA takes action to protect consumers from potentially dangerous counterfeit medicines and devices sold online 03 July 2015
FDA approves anti-clotting drug Savaysa 15 January 2015

Most Popular Now

A new method cuts the cost of drug-…

EPFL (École polytechnique fédérale de Lausanne) scientists design a new method to cheaply produce some of the most important chemical compounds in the pharmaceutical indu...

Read more

Six leading scientists to receive p…

Today Novartis announced that six scientists will receive the 2016 Novartis Prizes for Immunology at the upcoming 16th International Congress of Immunology (ICI) in Melbo...

Read more

Pfizer announces publication of new…

Pfizer Inc. (NYSE:PFE) announced the publication of a new post-hoc analysis of data from three studies of VYNDAQEL in patients with mild transthyretin familial amyloid po...

Read more

Bayer and CRISPR Therapeutics joint…

Casebia Therapeutics, the joint venture founded by Bayer and CRISPR Therapeutics, started its operations in Cambridge, MA, U.S. In December, 2015 Bayer and CRISPR Therape...

Read more

AstraZeneca and Lilly receive FDA F…

AstraZeneca and Eli Lilly and Company (Lilly) today announced they have received US Food and Drug Administration (FDA) Fast Track designation for the development programm...

Read more

Natural compound from a deep-water …

Scientists at Florida Atlantic University's Harbor Branch Oceanographic Institute found that a deep-water marine sponge collected off of Fort Lauderdale's coast contains ...

Read more

Pfizer to acquire small molecule an…

Pfizer Inc. (NYSE:PFE) today announced that it has entered into an agreement with AstraZeneca to acquire the development and commercialization rights to its late-stage sm...

Read more

Researchers develop safer opioid pa…

An international team of researchers - led by scientists at UC San Francisco, Stanford University, the University of North Carolina (UNC), and the Friedrich-Alexander Uni...

Read more

Amgen and Advaxis enter global canc…

Amgen (NASDAQ:AMGN) and Advaxis, Inc. (NASDAQ:ADXS) announced a global agreement for the development and commercialization of Advaxis' ADXS-NEO, a novel, preclinical inve...

Read more

Legions of nanorobots target cancer…

Researchers from Polytechnique Montréal, Université de Montréal and McGill University have just achieved a spectacular breakthrough in cancer research. They have develope...

Read more

Why is breast cancer common but hea…

Malignant cancers strike certain organs, such as the colon or breast, more often than others. In an Opinion publishing August 9 in Trends in Cancer, researchers propose t...

Read more

Esketamine receives Breakthrough Th…

Janssen Research & Development, LLC, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, announced that the U.S. Food and Drug Administration (FDA) has gran...

Read more

Digest World Pharma Newsletter

Subscribe to our weekly Digest Newsletter and stay updated on the latest World Pharma News. Subscribe now, it's free!

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]

© World Pharma News 2006 - 2016